Bharat Parenterals Ltd - 541096 - The Company Has Fixed Monday, September 25, 2023 As The Record Date For The Purpose Of Determining The Members Eligible To Receive The Final Dividend For The Financial Year Ended 2022-23.
The company has fixed record 25th September, 2023 for the purpose of determining the members eligible to receive the final dividend for the financial year 2022-23. Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting of the Company in its meeting held on Today i.e. Thursday, the 31st Day of August, 2023. Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Newspaper Publication
As per Regulations 30 and 47 of SEBI (Listing Operations and Disclosure Requirements) Regulations, 2015 please find enclosed Extracts of the newspaper publications published in Business Standards and Loksatta jansatta on 10th August, 2023, relating to the unaudited standalone and consolidated financial results for the quarter ended on 30th June, 2023. Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Unaudited Financial Results For The Quarter Ended 30Th June, 2023.
In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 09th August, 2023, has considered and approved the Unaudited Financial Results for the Quarter ended 30th June, 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 2015, we bring to your kind attention that the Company/RTA has issued duplicate share certificates. Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors For Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2023.
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 ,inter alia, to consider and approve The unaudited financial results of the Company for the Quarter ended on June 30, 2023. Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for Loss of share certificates. Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
RTA Confirmation certificate pursuant to Provisions of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Bharat Parenterals Ltd - 541096 - Closure of Trading Window
Closure of trading window as per company''s code of conduct framed in accordance with SEBI ( Prohibition of Insider Trading) Regulations, 2015 from 01st July, 2023 onwards till 48 hours after the declaration of unaudited Financial Results for the Quarter ended on 30th June, 2023 (Both days inclusive). Bharat Parenterals Ltd - 541096 - Declaration
In compliance of Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015